Application Sponsors
ANDA 216932 | TEVA PHARMS INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 20MG | 0 | ALYQ | TADALAFIL |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-10-12 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
TEVA PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 216932
[companyName] => TEVA PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"ALYQ","activeIngredients":"TADALAFIL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/12\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-10-12
)
)